However, it has also been shown that the mRNA expression of I-FABP does not change considerably in the dexamethasone-induced intestinal disorder model or infection with Campylobacter jejuni [37, 38], which might be due to the different disease models and severity. The gene discussed is FABP2; the disease is intestinal disorder.